Although it wasn't all that long ago that Stryker (NYSE: SYK )
traded at a pretty meaningful discount to fair value, Wall Street has
come back around to the enduring value of one of the better-run names in
the sector. Helping matters greatly is a recovery in major joint
reconstruction and early success with margin improvement initiatives.
These shares are no longer a tremendous bargain, but they're still
priced to generate decent long-term returns for long-term shareholders.
Please follow this link for more:
http://www.fool.com/investing/general/2013/10/18/strong-recon-pushing-strykers-rebound.aspx
No comments:
Post a Comment